Martin Shkreli, the former hedge fund manager who became infamous for buying a life-saving drug and then raising the price significantly, was led away in handcuffs by the FBI last week. Unfortunately, the Boston Globe editorial board reminds us, “viewing his much-publicized takedown as anything like a tipping point in the push for pharmaceutical industry reform would be a mistake.”
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.